Sugi Predict

Sugi Predict / Compounds / SCHEMBL878428

SCHEMBL878428

SCHEMBL878428

[CH2]C1NCCc2ccccc21

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PRCP P42785 8/20 0.59
▸ GAA P10253 2/20 0.56
▸ SLC22A1 O15245 1/20 0.56
▸ RECQL P46063 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ GID4 Q8IVV7 1/20 0.47
▸ HTR2A P28223 1/20 0.47
▸ HTR2C P28335 1/20 0.47
▸ HTR2B P41595 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ OPRM1 P35372 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1717271 0.79 PRCP (0.65) PRCPGAASLC22A1SMN1; SMN2KDM4E
SCHEMBL16799768 0.78 PRCP (0.70) PRCPGAASLC22A1RECQLTSHR
SCHEMBL24017043 0.78 PRCP (0.70) PRCPGAASLC22A1RECQLTSHR
SCHEMBL873419 0.78 CYP2D6 (0.41) PRCPTSHRKDM4EALDH1A1
SCHEMBL30368634 0.78 PRCP (0.70) PRCPGAASLC22A1RECQLTSHR
SCHEMBL13977536 0.76 PRCP (0.67) PRCPGAASLC22A1SMN1; SMN2KDM4E
SCHEMBL4340396 0.76 PRCP (0.61) PRCPGAASLC22A1SMN1; SMN2KDM4E
SCHEMBL8823898 0.75 PRCP (0.58) PRCPGAASLC22A1RECQLTSHR
SCHEMBL327738 0.75 PRCP (0.61) PRCPGAASLC22A1RECQLTSHR
SCHEMBL327182 0.75 PRCP (0.58) PRCPGAASLC22A1RECQLTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113683616-A KRAS G12C mutein inhibitors 广州百霆医药科技有限公司 2021-11-23 — — CN claimed
CN-109574947-A The Oxazolidinone derivative and preparation method thereof of the structure of hydrazone containing biaryl 沈阳药科大学 2019-04-05 — — CN claimed
CN-107721943-A Jie Gou oxazolidinone compounds of hydrazone containing biaryl and preparation method thereof 沈阳药科大学 2018-02-23 — — CN claimed
CN-107266449-A The preparation method of chiral 8 (base of 3 amino piperidine 1) xanthine 勃林格殷格翰国际有限公司 2017-10-20 — — CN claimed
CN-104592235-B Intermediate for preparing compound as dipeptidyl peptidase-4 inhibitor ZHEJIANG YONGTAI TECHNOLOGY CO.,LTD. (CN) 2016-01-20 — — CN claimed
CN-102127080-B Chirality 8-(3-amino-piperadine-1-base)-xanthic preparation method BOEHRINGER INGELHEIM INT (DE) 2016-01-20 — — CN claimed
CN-104955826-A SPIRO-QUINAZOLINONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS MERCK PATENT GMBH 2015-09-30 — — CN claimed
CN-104592235-A Intermediate for preparing compound as dipeptidyl peptidase-4 inhibitor ZHEJIANG YONGTAI TECHNOLOGY CO LTD 2015-05-06 — — CN claimed
CN-104478880-A Biguanide derivative as DPP-IV (dipeptidyl peptidase-4) inhibitor ZHEJIANG YONGTAI TECHNOLOGY CO LTD 2015-04-01 — — CN claimed
CN-104478879-A Compound as dipeptidyl peptidase-4 inhibitor ZHEJIANG YONGTAI TECHNOLOGY CO LTD 2015-04-01 — — CN claimed
US-7304086-B2 Inhibitors of glutaminyl cyclase PROBIODRUG AG (DE) 2007-12-04 — — US claimed
US-20070105863-A1 e.g. 1-(8-(3-hydroxyphenyl)-7,8-dimethyl-hexahydro-1H-pyrido[1,2- alpha ]pyrazin-2(6H)-yl)-2-phenylethanone; analgesics; gastrointestinal dysfunction, post-surgical recovery; side effect reduction MERCK SHARP & DOHME LLC 2007-05-10 — — US claimed
WO-2007050802-A2 NOVEL OPIOID ANTAGONISTS ADOLOR CORPORATION (US) 2007-05-03 — — WO claimed
US-20030055261-A1 Compounds with growth hormone releasing properties HELSINN THERAPEUTICS (U.S.), INC. 2003-03-20 — — US claimed
US-20030040483-A1 Compounds with growth hormone releasing properties HELSINN THERAPEUTICS (U.S.), INC. 2003-02-27 — — US claimed
CN-1211991-A Compounds with growth hormone releasing properties NOVO NORDISK AS (DK) 1999-03-24 — — CN claimed
EP-0869974-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1998-10-14 — — EP claimed
WO-1997023508-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1997-07-03 — — WO claimed
EP-0188254-B1 CEPHEM COMPOUNDS, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-03-24 — — EP claimed
EP-0188254-A2 Cephem compounds, processes for preparation thereof and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-07-23 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055261-A1 Compounds with growth hormone releasing properties GHRHR, GHSR, IGFBP1 PRCP 1125/4885GAA 541/4885SLC22A1 1569/4885
US-20070105863-A1 e.g. 1-(8-(3-hydroxyphenyl)-7,8-dimethyl-hexahydro-1H-pyrido[1,2- alpha ]pyrazin-2(6H)-yl)-2-phenylethanone; analgesics; gastrointestinal dysfunction, post-surgical recovery; side effect reduction OPRK1, OPRD1, OPRM1 PRCP 2365/4885GAA 2253/4885SLC22A1 3936/4885
US-20030040483-A1 Compounds with growth hormone releasing properties GHRHR, GHSR, GRPR PRCP 1009/4885GAA 738/4885SLC22A1 1685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.